Medtronic plc — Director's Dealing 2018

Jan 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-01-09

Reporting Person: Kuntz Richard (SrVP & Chief Scien, Clin, Reg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-09	Ordinary Shares	M	35492	$37.53	Acquired	149761	Direct
2018-01-09	Ordinary Shares	M	45872	$34.88	Acquired	195633	Direct
2018-01-09	Ordinary Shares	S	78526	$86.21	Disposed	117107	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-09	Stock Option (Right to Buy)	$37.53	M	35492	Disposed	2020-08-02	Ordinary Shares (35492)	Direct
2018-01-09	Stock Option (Right to Buy)	$34.88	M	45872	Disposed	2021-08-01	Ordinary Shares (45872)	Direct

Footnotes

F1: This balance increased by 324 shares due to exempt transactions such as dividend reinvestment.

F2: The price reported in Column 4 is a weighted Average price. The shares were sold in multiple transactions at prices ranging from $86.12 to $86.26, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

F3: This option to purchase 35,492 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 35,492 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 45,872 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 45,872 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.